Comments

CytoDyn (CYDY) Stock Price, Quote, News & History

CYDYOTCQB

Logo brought to you by Benzinga Data

Trade with Public

$0.3036

-0.0191-5.92%

At close: Dec 15, 4:00 PM EST

Overview

News Insider Trades Short Interest

Key Statistics

Open

$0.32

$0.30

Volume / Avg.

1.74M / 1.86M

Day Range

$0.30 - $0.33

52 Wk Range

0.11 - 0.49

Market Cap

$384.31M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

5.86

Recent Cytodyn Inc News

A Penny Stock To Watch In Challenging Cancer Space

The author has a $2.75 Price Target on CytoDyn (CYDY) in the Next 6 to 12 months, representing significant upside from its current price of around $0.32.

James Gornick

Partner Content

Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December

On December 14th, the Federal Reserve hiked its key interest rate by 50 basis points. This was the first deceleration in rate hike increases in 2022; between March and November 2022, the interest rate had jumped 25 basis points, 50 basis points and then 75 points four times in a row in between each Federal Reserve meeting.

Partner Content

OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes

The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 5.56% in November, recording two subsequent monthly increases for the first time in 2022.

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Key Statistics

Open

$0.32

$0.30

Volume / Avg.

1.74M / 1.86M

Day Range

$0.30 - $0.33

52 Wk Range

0.11 - 0.49

Market Cap

$384.31M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

5.86

About

Sector

Health Care

Industry

Biotechnology

CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The product candidate i...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CytoDyn (CYDY) stock?

You can purchase shares of CytoDyn (OTCQB:CYDY) through any online brokerage.

View our list of the best stock brokerages

Who are CytoDyn (CYDY) competitors?

There are no as such competitors for CytoDyn.

What is the forecast, or price target, for CytoDyn (CYDY) stock?

There is no analysis for CytoDyn to provide a consensus price target.

What is the current price for CytoDyn (CYDY)?

The stock price for CytoDyn (OTCQB: CYDY) is $0.3036 last updated December 15, 2025 at 3:59 PM EST.

Does CytoDyn (CYDY) pay a dividend?

There are no upcoming dividends for CytoDyn.

When is CytoDyn (OTCQB:CYDY) reporting earnings?

CytoDyn does not have any upcoming earnings scheduled.

Is CytoDyn (CYDY) going to split?

There is no upcoming split for CytoDyn.

What sector and industry does CytoDyn (CYDY) operate in?

CytoDyn is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.